Focusing on the Revised Schedule M of the Drugs and Cosmetics Act 1940, the Central Drug Research Institute (CDRI) in Lucknow in Uttar Pradesh will hold one industry conclave-cum-panel discussions on ...

The Indian Institute of Science (IISc) and University College London (UCL) have initiated a new strategic partnership to advance collaborative efforts in healthcare innovation. This follows after a ...

The Indian Council of Medical Research (ICMR) has announced an open call for proposals under its Centre for Advanced Research (CAR) scheme to support clinical studies for medical device and diagnostic ...

Digital technologies have transformed biology research to provide in-depth insights into unravelling the mysteries of living systems. Bioengineering is the new frontier in advanced technology, said ...

In order to better streamline the approval process for manufacturing license to the medical devices units, the Central government is looking at amending the relevant rules in the Medical Device Rules ...

Novartis announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. Previous guidance for +5% sales CAGR 2023-2028 was ...

BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Ayrmid Ltd. (Ayrmid), the parent company of Gamida Cell Ltd., announced ...

Study links rare genetic mutation to severe neurological disorder: Krems, Austria Friday, November 22, 2024, 11:00 Hrs [IST] A recent study has uncovered the intricate ways in whi ...

Our Bureau, Mumbai Thursday, November 21, 2024, 17:30 Hrs [IST] ...

US FDA approves Jazz Pharma’s Ziihera to treat adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer: Dublin Friday, November 22, 2024, 1 ...

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General’s ...

Abbott announced that, in the third year of its multi-million-dollar Diversity in Clinical Trials initiative, the company has published 'Advancing Diversity in Clinical Trials' to share strategies to ...